JP2019501161A5 - - Google Patents

Download PDF

Info

Publication number
JP2019501161A5
JP2019501161A5 JP2018532037A JP2018532037A JP2019501161A5 JP 2019501161 A5 JP2019501161 A5 JP 2019501161A5 JP 2018532037 A JP2018532037 A JP 2018532037A JP 2018532037 A JP2018532037 A JP 2018532037A JP 2019501161 A5 JP2019501161 A5 JP 2019501161A5
Authority
JP
Japan
Prior art keywords
composition
use according
blue light
light
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018532037A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019501161A (ja
JP6995755B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/081809 external-priority patent/WO2017103285A1/en
Publication of JP2019501161A publication Critical patent/JP2019501161A/ja
Publication of JP2019501161A5 publication Critical patent/JP2019501161A5/ja
Application granted granted Critical
Publication of JP6995755B2 publication Critical patent/JP6995755B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018532037A 2015-12-17 2016-12-19 膀胱癌に対する光線力学的療法(pdt)の方法 Active JP6995755B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15200938 2015-12-17
EP15200938.7 2015-12-17
PCT/EP2016/081809 WO2017103285A1 (en) 2015-12-17 2016-12-19 Method of photodynamic therapy (pdt) for bladder cancer

Publications (3)

Publication Number Publication Date
JP2019501161A JP2019501161A (ja) 2019-01-17
JP2019501161A5 true JP2019501161A5 (enExample) 2020-02-06
JP6995755B2 JP6995755B2 (ja) 2022-01-17

Family

ID=55066354

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018532037A Active JP6995755B2 (ja) 2015-12-17 2016-12-19 膀胱癌に対する光線力学的療法(pdt)の方法

Country Status (18)

Country Link
US (2) US11235168B2 (enExample)
EP (1) EP3389716B1 (enExample)
JP (1) JP6995755B2 (enExample)
KR (1) KR102787192B1 (enExample)
CN (2) CN108697800A (enExample)
AU (1) AU2016372575B2 (enExample)
BR (1) BR112018011965A2 (enExample)
CA (1) CA3008552C (enExample)
CL (1) CL2018001612A1 (enExample)
DK (1) DK3389716T3 (enExample)
ES (1) ES2910034T3 (enExample)
IL (1) IL259925B (enExample)
MX (1) MX385912B (enExample)
PL (1) PL3389716T3 (enExample)
RU (1) RU2745194C2 (enExample)
SG (1) SG11201805000RA (enExample)
WO (1) WO2017103285A1 (enExample)
ZA (1) ZA201804530B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201805000RA (en) * 2015-12-17 2018-07-30 Photocure Asa Method of photodynamic therapy (pdt) for bladder cancer
CN110420326A (zh) * 2019-09-17 2019-11-08 上海复旦张江生物医药股份有限公司 一种多替泊芬的应用
JP7769015B2 (ja) * 2021-08-17 2025-11-12 ボストン サイエンティフィック サイムド,インコーポレイテッド 光活性剤を活性化するためのカテーテルシステム及びカテーテル
WO2024184417A1 (en) 2023-03-07 2024-09-12 Photocure Asa Therapy for bladder cancer

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2157424T3 (es) 1995-03-10 2001-08-16 Photocure Asa Esteres de acido 5-aminolevulinico como agentes fotosensibilizantes en fotoquimioterapia.
US7530461B2 (en) * 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US20050003154A1 (en) * 2002-12-13 2005-01-06 White Gary L. Laminated building panels having preselected colors
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
GB0700580D0 (en) 2007-01-11 2007-02-21 Photocure Asa Use
GB0724279D0 (en) 2007-12-12 2008-01-23 Photocure Asa Use
CN101891639A (zh) 2009-05-20 2010-11-24 上海先导化学有限公司 一种制备5-氨基酮戊酸盐酸盐的方法
SI2440199T1 (sl) 2009-06-11 2016-05-31 Photocure Asa Poltrdni sestavki in farmacevtski proizvodi
US20120134921A1 (en) 2009-06-11 2012-05-31 Photocure Asa Solid compositions comprising 5-aminolevulinic acid
RU2448745C2 (ru) * 2010-05-31 2012-04-27 Олег Феликсович Каган Способ лечения поверхностного рака мочевого пузыря
US20150088001A1 (en) 2011-12-19 2015-03-26 Technical University Of Denmark Illumination System for Endoscopic Applications
SG11201500805VA (en) 2012-08-03 2015-02-27 Photocure Asa Compounds
GB201221123D0 (en) * 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
SG11201805000RA (en) * 2015-12-17 2018-07-30 Photocure Asa Method of photodynamic therapy (pdt) for bladder cancer

Similar Documents

Publication Publication Date Title
JP2014094963A5 (enExample)
JP2019501161A5 (enExample)
AR072442A1 (es) Metodo para la terapia del cancer, uso, kit
ME01133B (me) Kombinovana terapija sa peptidnim epoksiketonima
EP2754439A3 (en) Use of aminolevulinic acid derivatives
EA201100030A1 (ru) Пиразольные соединения 436
JP2009519312A5 (enExample)
AR075423A1 (es) Composicion farmaceutica que comprende un inhibidor de sglt-2, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y sus usos
MX360684B (es) Silicato de zirconio microporoso para el tratamiento de la hipercalemia.
RU2013156378A (ru) 4-амино-5-фтор-3-[6-(4-метилпиперазин-1-ил)-1н-бензимидазол-2-ил]-1н-хинолин-2-он для применения при лечении аденокистозной карциномы
JP2018537514A5 (enExample)
AR107828A1 (es) 2-amino-n-[7-metoxi-2,3-dihidroimidazo-[1,2-c]quinazolin-5-il]pirimidin-5-carboxamidas como inhibidor de pi3k
US11980772B2 (en) Method of photodynamic therapy (PDT) for bladder cancer
CY1123583T1 (el) Ανοσογονος συνθεση για χρηση στη θεραπεια
PE20181332A1 (es) Metodos de sedacion y formulacion parenteral para uso durante el tratamiento de cuidados criticos
ATE543492T1 (de) Behandlung von lungenkrebs
JP2018538308A5 (enExample)
EA200700637A1 (ru) Соли донепезила, подходящие для получения фармацевтических композиций
CL2016002318A1 (es) Composición farmacéutica en forma de solución que comprende un portador líquido que comprende agua y entre 20% y 95% de uno o mas alcoholes y citrato de sildenafil disuelto en dicho portador líquido a una concentración de entre 7 y 125 mg/ml; métodos para obtenerla; forma de dosificación oral; forma de dosificación bucal; kits.
JP2015528515A5 (enExample)
CY1106950T1 (el) Μονοενυδρο αλας νατριου της s-tενατοπραζολης και εφαρμογη υπο τυπον αναστολεα αντλιας πρωτονιων
NZ743697B2 (en) Method of photodynamic therapy (pdt) for bladder cancer
BR112022001814A2 (pt) Métodos de tratamento de câncer multifocal
TW200509945A (en) Agent for treatment of anal disease
RU2018124868A (ru) Неоадъювантная терапия для рака мочевого пузыря